Best Foundayo Providers 2026

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Foundayo (orforglipron) is the newest FDA-approved oral GLP-1 from Eli Lilly, and the cash-pay marketplace around it has matured fast. The full-service telehealth providers prescribing Foundayo today — Ro, Found, Sesame Care, Weight Watchers Med+, and Form Health — are all viable for a commercially insured patient with a covered formulary. The picture changes the moment your insurance excludes weight-loss drugs, your coverage is government-backed, or you want a treatment plan anchored to your genetics rather than a population-average titration. This roundup walks the best Foundayo provider options for 2026, explains where each one wins, and shows where the PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol belong on the same shortlist as a cash-pay, no-membership alternative built around the Precision Peptide Genetic Test.

The 2026 Foundayo provider landscape at a glance

Foundayo is a brand-name, patent-protected oral GLP-1 — there is no FDA-approved compounded orforglipron, and any provider advertising one should be treated as a red flag. That narrows the legitimate Foundayo provider list to telehealth companies that prescribe and route fills through commercial pharmacies. Among the verified providers, Ro ($39 first month, then $149/mo or about $74/mo annual) is the most polished insurance-concierge experience for commercially insured shoppers. Found (plans from $17/mo) is the lowest-fee insurance-first option. Form Health is the only board-certified obesity medicine clinic on the list and the only Foundayo provider that bills Medicare directly when the plan covers obesity care. Sesame Care is a clinician marketplace ($59–$99/mo) where you choose your own provider. Weight Watchers Med+ ($25 first month, then $74/mo on the 12-month plan) layers coaching onto the same prescribing flow. LillyDirect is the manufacturer-direct fill path with no platform fee, ranging $149-$289/mo by dose. None of these prescribe compounded GLP-1s. If your insurance excludes weight-loss drugs and you want a compounded GLP-1 path with genetic-baselined dosing, that’s where PlexusDx fits as an alternative rather than a Foundayo substitute.

What Foundayo really costs after month one

The $25/month Foundayo headline is real but conditional — it requires commercial drug insurance that lists Foundayo on its formulary plus enrollment in the Foundayo Savings Card, capped at roughly 10 fills per year. Without a covered formulary, the Savings Card holds cash cost at $149 (0.8 mg starting), $199 (2.5 mg), and $299–$349 at the higher 5.5–17.2 mg doses through LillyDirect. Government-insurance recipients (Medicare, Medicaid, TRICARE, VA) are not eligible for the commercial Savings Card. Add the provider’s membership or visit fee — $39–$149 first month at Ro, $17–$74/mo on Found, $25–$74/mo on WW Med+, $59–$99/mo on Sesame — and the all-in monthly cost in the cash-pay lane sits between roughly $166 and $448/mo. That total is the right comparison number, not the headline. Cash-pay PlexusDx Weight Management Protocols, by contrast, bundle async clinician consult, prescription, compounded medication, and shipping into one bill: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, Semaglutide Oral from $249/mo, Tirzepatide Oral at $279/mo, and GLP-Squared dual-compound at $249/mo. No membership fee on top.

Ro — the default for commercially insured Foundayo shoppers

Ro’s pull on this category is the dedicated insurance concierge that submits prior authorization paperwork on the patient’s behalf. PA timelines for Foundayo run 7–21 days from submission to decision and the actual delay is almost always at the submission step — that’s the friction Ro removes. Ro’s base pricing is $39 first month, then $149/mo, or roughly $74/mo on the annual plan. With covered commercial insurance plus the Savings Card, your medication can drop to $25/mo for up to 10 fills per year. Ro is the best fit for a reader with a commercial plan that already covers GLP-1s and who wants the smoothest PA experience. It is not the right fit for Medicare patients or readers whose plans exclude weight-loss drugs — in that case the medication math collapses back to LillyDirect cash, and the membership fee becomes pure overhead.

Found, Form Health, Sesame, and Weight Watchers Med+ — where each one wins

Beyond Ro, four other Foundayo providers each occupy a distinct niche. Found wins on platform fee — plans starting at $17/mo — and on insurance-specialist outreach to in-network plans. Form Health is the only obesity-medicine clinic in the field; it bills most major private insurance and Medicare directly under an insurance-billed care model and is the right pick for Medicare readers and for patients who want a true clinical relationship with a board-certified obesity physician (self-pay program: $299/mo, medication separate). Sesame Care works as a clinician marketplace where you pick the provider; pricing runs $59/mo on the annual plan up to $99/mo monthly, and PA handling is provider-dependent. Weight Watchers Med+ couples Foundayo prescribing with the WW coaching framework, $25 first month then $74/mo on a 12-month commitment — useful for readers who want behavioral accountability bolted to the medication.

Where PlexusDx fits on a Foundayo shortlist

PlexusDx does not prescribe Foundayo. It prescribes compounded semaglutide and tirzepatide across four delivery formats — weekly injection, daily oral, microdose troche/capsule/lozenge/sublingual, and a dual-compound stack — through licensed U.S. compounding pharmacies. So PlexusDx belongs on this shortlist only when one of three things is true: (1) your insurance excludes weight-loss drugs and the Foundayo math collapses to ~$166–$448/mo all-in cash, where Microdose GLP-1 Protocol at $129/mo flat or Semaglutide Injection at $149/mo is meaningfully cheaper; (2) you want injectable semaglutide or tirzepatide rather than an oral pill, since Foundayo is oral-only and PlexusDx covers all four delivery formats; or (3) you want the prescribing clinician to see your GIPR rs1800437 status and 33 other weight-management genetic insights before titration, which is what the Precision Peptide Genetic Test ($298 standalone, or $99 as an add-on after your first month on any protocol) provides. PlexusDx is cash-pay, no membership, all 50 states — five states require a scheduled live consult instead of async intake.

Compounded vs FDA-approved branded — what each path actually dispenses

This is the substantive medication difference and it matters more than provider polish. Foundayo is an FDA-approved finished drug product — the same orforglipron tablets used in Lilly’s ATTAIN trials, dispensed through commercial pharmacies. PlexusDx Weight Management Protocols dispense compounded semaglutide and tirzepatide — pharmacy-prepared formulations of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound, prepared under U.S. compounding regulations. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. The active ingredients are well-characterized and PlexusDx’s pharmacies are licensed; what changes is the regulatory framework over the finished product, not the molecule. The boxed warning for thyroid C-cell tumors based on rodent studies applies to both semaglutide and tirzepatide regardless of finished-product source.

Genetics-informed dosing — the variable none of the Foundayo providers test

GLP-1 response varies meaningfully across patients. Variants in GLP1R, FTO, MC4R, TCF7L2, and the GIPR rs1800437 polymorphism have been associated with measurably different response patterns to GLP-1 receptor agonists and GIP/GLP-1 dual agonists. None of the Foundayo providers — Ro, Found, Form Health, Sesame, WW Med+, or LillyDirect — runs a genetic baseline before dose selection. Each starts from a population-average titration schedule and adjusts on subjective tolerability over the first 8–12 weeks. The PlexusDx Precision Peptide Genetic Test maps 48 genes, 57 variants across 14 health pathways, and 150+ genetic insights including 34 weight-management variants, then surfaces the result through the Peptide Pathways Report in the Results Portal. For a patient who’s already failed one GLP-1 titration on a different platform, or who simply wants the prescribing clinician to see their biology before week one, that genetic baseline is the variable PlexusDx adds and Foundayo providers don’t. It’s available standalone for $298, or as a $99 add-on after your first month on any of the six Weight Management Protocols.

How to choose — a four-question decision frame

Question 1: Do you have commercial insurance that lists Foundayo on its formulary? If yes, Ro is the default for the smoothest PA experience; Form Health is the alternative if you want an obesity-medicine clinical relationship. Question 2: Are you on Medicare? Form Health is the only Foundayo provider that bills Medicare directly under the obesity-care model — until the Medicare GLP-1 Bridge launches July 1, 2026, statutory exclusion still applies for weight-loss-only indications. Question 3: Does your plan exclude weight-loss drugs and price is the dominant variable? Compare LillyDirect Foundayo cash ($149-$289/mo) to PlexusDx Microdose GLP-1 Protocol at $129/mo flat or Semaglutide Injection at $149/mo — PlexusDx wins on cost in this lane and includes the clinician consult in the protocol price. Question 4: Do you want an injectable GLP-1, a dual-agonist tirzepatide, or genetics-informed dose selection before week one? Foundayo is oral orforglipron only and none of its providers genotype — PlexusDx covers all four delivery formats and pairs the protocol with the Precision Peptide Genetic Test.

Frequently asked questions

Does insurance cover Foundayo in 2026?

Some commercial drug plans cover Foundayo on formulary, almost always with prior authorization (7–21 day timeline). Medicare Part D statutorily excludes weight-loss drugs through June 30, 2026; the Medicare GLP-1 Bridge launches July 1, 2026 at a flat $50/month copay for eligible Part D beneficiaries, with Foundayo’s inclusion pending CMS confirmation. Medicaid coverage is state-by-state and most states still exclude weight-loss drugs. PlexusDx is cash-pay only and does not bill insurance.

Can I really get Foundayo for $25/month?

Only if you have commercial drug insurance that covers Foundayo on its formulary AND you enroll in the Foundayo Savings Card, capped at about 10 fills per year. Without coverage the card caps cash cost at $149-$289/mo by dose. Government-insurance recipients (Medicare, Medicaid, TRICARE, VA) cannot use the commercial Savings Card. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is a cash-pay alternative when the $25 lane isn’t available to you.

Which telehealth providers prescribe Foundayo today?

As of April 2026, the verified full-service telehealth Foundayo providers are Ro, Found, Sesame Care, Weight Watchers Med+, and Form Health. LillyDirect is the manufacturer-direct fill path. Amazon Pharmacy and One Medical handle fills and limited renewals but are not new-prescription programs. PlexusDx is not a Foundayo provider — it prescribes compounded semaglutide and tirzepatide across four delivery formats.

Is Foundayo available through Hims or Hers?

No — Foundayo is not currently listed on the public Hims and Hers weight-loss product pages. The 2026 Hims/Hers Novo Nordisk partnership covers Wegovy and Ozempic, not Foundayo. If you want a similar oral GLP-1 path on those platforms, the Wegovy oral tablet is the available option there.

How does Foundayo compare to PlexusDx for someone with no insurance?

Foundayo through LillyDirect is $149/mo at the 0.8 mg starting dose and $299–$349/mo at the higher doses, with no platform fee. PlexusDx Microdose GLP-1 Protocol is $129/mo flat all-inclusive and the Semaglutide Injection is $149/mo all-inclusive of consult, medication, and shipping. PlexusDx is the cheaper cash-pay path on the lower tiers and adds the optional Precision Peptide Genetic Test for genetic-baselined dosing.

Is compounded orforglipron available anywhere?

No. Foundayo (orforglipron) is a patent-protected, FDA-approved brand-name medication and there is no FDA-approved compounded orforglipron product. Any provider marketing “compounded orforglipron” should be treated as a red flag. PlexusDx prescribes compounded semaglutide and tirzepatide only, never compounded orforglipron.

What happens if my Foundayo prior authorization is denied?

Standard playbook: file an appeal with a Letter of Medical Necessity through your prescribing provider, and switch to LillyDirect self-pay ($149/mo starting dose) so you don’t lose treatment time during the appeal. Your Ro, Found, or Form Health clinician can also prescribe an alternative FDA-approved GLP-1 your plan does cover. If a long-term cash-pay path is the better fit, the PlexusDx Semaglutide Injection or Tirzepatide Injection protocols are bundled-pricing alternatives.

Best Foundayo Alternatives (2026): Top Providers and Where PlexusDx Fits | PlexusDx

Compare the 2026 best Foundayo (orforglipron) providers — Ro, Found, Form Health, Sesame Care, Weight Watchers Med+, and LillyDirect — and see where the PlexusDx Weight Management Protocols fit as a cash-pay, genetics-informed alternative when insurance excludes weight-loss drugs.